Adult primary central nervous system vasculitis treatment and course: Analysis of one hundred sixty-three patients

Arthritis and Rheumatology

Volumn 67, Issue 6, 2015, Pages 1637-1645

  Salvarani, Carlo ^a,b   Brown, Robert D ^a   Christianson, Teresa J H ^a   Huston, John ^a   Giannini, Caterina ^a   Miller, Dylan V ^a   Hunder, Gene G ^a  

^a MAYO CLINIC   (United States)

^b Azienda Ospedaliera di Reggio Emilia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GADOLINIUM; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; RITUXIMAB; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN VASCULITIS; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINX; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIMARY CENTRAL NERVOUS SYSTEM VASCULITIS; PRIORITY JOURNAL; RANKIN SCALE; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; VASCULAR AMYLOIDOSIS; COMPLICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; VASCULITIS, CENTRAL NERVOUS SYSTEM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL AMYLOID ANGIOPATHY; COHORT STUDIES; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDNISONE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; VASCULITIS, CENTRAL NERVOUS SYSTEM; YOUNG ADULT;

EID: 84929931397     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39068     Document Type: Article

References (21)

1. Salvarani C, Brown RD Jr, Hunder GG., Adult primary central nervous system vasculitis. Lancet 2012; 380: 767-77.
2. Calabrese LH, Mallek JA., Primary angiitis of the central nervous system: report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 1988; 67: 20-39.
3. Salvarani C, Brown RD Jr, Hunder GG., Adult primary central nervous system vasculitis: an update. Curr Opin Rheumatol 2012; 24: 46-52.
4. Cravioto H, Feigin I., Noninfectious granulomatous angiitis with a predilection for the nervous system. Neurology 1959; 9: 599-609.
5. Lie JT., Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature. Hum Pathol 1992; 23: 164-71.
6. Cupps TR, Moore PM, Fauci AS., Isolated angiitis of the central nervous system: prospective diagnostic and therapeutic experience. Am J Med 1983; 74: 97-105.
7. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, et al., Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007; 62: 442-51.
8. De Boysson H, Zuber M, Naggara O, Neau JP, Gray F, Bousser MG, et al, for the French Vasculitis Study Group and the French NeuroVascular Society. Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system. Arthritis Rheumatol 2014; 66: 1315-26.
9. Oon S, Roberts C, Gorelik A, Wicks I, Brand C., Primary angiitis of the central nervous system: experience of a Victorian tertiary-referral hospital. Intern Med J 2013; 43: 685-92.
10. Birnbaum J, Hellmann DB., Primary angiitis of the central nervous system. Arch Neurol 2009; 66: 704-9.
11. Sulter G, Steen C, De Keyser J., Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999; 30: 1538-41.
12. Molloy ES, Langford CA., Advances in the treatment of small vessel vasculitis. Rheum Dis Clin North Am 2006; 32: 157-72.
13. Salvarani C, Brown RD Jr, Calamia KT, Christianson T, Huston J III, Meschia JF, et al., Rapidly progressive primary central nervous system vasculitis. Rheumatology (Oxford) 2008; 50: 349-58.
14. Salvarani C, Brown RD Jr, Morris JM, Huston J III, Hunder GG,. Catastrophic primary central nervous system vasculitis. Clin Exp Rheumatol 2014; 32: S3-4.
15. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J III, Meschia JF, et al., Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford) 2008; 47: 1671-7.
16. Salvarani C, Hunder GG, Morris JM, Brown RD Jr, Christianson T, Giannini C,. Aβ-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology 2013; 81: 1596-603.
17. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J III, Meschia JF, et al., Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels. Medicine (Baltimore) 2008; 87: 264-71.
18. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Huston J III, Meschia JF, et al., Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome. Arthritis Rheum 2008; 58: 595-603.
19. Salvarani C, Brown RD Jr, Calamia KT, Huston J III, Meschia JF, Giannini C, et al., Efficacy of tumor necrosis factor α blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment. Arthritis Rheum 2008; 59: 291-6.
20. Salvarani C, Brown RD Jr, Huston J III, Morris JM, Hunder GG., Treatment of primary CNS vasculitis with rituximab: case report. Neurology 2014; 82: 1287-8.
21. De Boysson H, Arquizan C, Guillevin L, Pagnoux C., Rituximab for primary angiitis of the central nervous system: report of 2 patients from the French COVAC cohort and review of the literature. J Rheumatol 2013; 40: 2102-3.